Table 2.
MDCT and Mapping Data
| Pt | MDCT | Mapping | Mapping Points | Low Voltage Area (cm2) | LAVA Location | |||
|---|---|---|---|---|---|---|---|---|
| RVEDV/BSA (mL/m2) | RV Free Wall Fat (%) | Endo | Epi | Endo | Epi | |||
| 1 | 150.33 | 11.35 | Endo | 1038 | NA | 23 | NA | Endo (basal Inf) |
| 2 | 153.78 | 18.21 | Endo+Epi | 1040 | 414 | 31.4 | 154.3 | Endo (basal Inf), Epi (basal Ant, Inf) |
| 3 | 91.82 | 17.43 | Endo+Epi | 461 | 1351 | 57.7 | 139 | Endo (basal Inf), Epi (basal Ant, Inf) |
| 4 | 126.97 | 11.63 | Endo+Epi | 725 | 584 | 36.7 | 150.5 | Endo (basal Inf, Lat), Epi (basal Lat) |
| 5 | 144.93 | 21.01 | Endo+Epi | 375 | 821 | 64.7 | 120.6 | Endo (basal/mid Lat), Epi (basal/mid Lat) |
| 6 | 74.29 | 19.79 | Endo+Epi | 220 | 580 | 21.1 | 97.6 | Epi (basal Lat) |
| 7 | 172.25 | 18.64 | Endo+Epi | 845 | 501 | 84.3 | 130.5 | Endo (basal Ant), Epi (basal Ant) |
| 8 | 160.82 | 12.72 | Endo+Epi | 301 | 331 | 60.2 | 104 | Endo (basal Inf, Lat), Epi (basal Ant, Lat) |
| 9 | 146.52 | 22.51 | Endo+Epi | 327 | 234 | 70.7 | 168.2 | Endo (basal Ant, Lat), Epi (basal Ant, Lat) |
| 10 | 84.23 | 9.69 | Endo+Epi | 1201 | 462 | 40.7 | 121 | Endo (basal Inf), Epi (basal Inf) |
| 11 | 135.92 | 12.85 | Endo+Epi | 510 | 667 | 2.3 | 63.7 | Epi (basal Ant) |
| 12 | 97.53 | 10.88 | Endo+Epi | 278 | 654 | 2 | 84.1 | Epi (apex, basal Ant, Lat) |
| 13 | 152.32 | 13.50 | Endo+Epi | 435 | 415 | 73.6 | 100.6 | Endo (basal Inf, Lat), Epi (basal Inf, Lat) |
| 14 | 152.95 | 18.73 | Endo | 650 | NA | 70.5 | NA | Endo (apex, mid Ant, basal Inf) |
| 15 | 111.76 | 21.53 | Endo | 1172 | NA | 90 | NA | Endo (apex, basal Lat) |
| 16 | 114.64 | 8.58 | Endo+Epi | 445 | 467 | 16 | 65 | Endo (basal Inf), Epi (basal Inf) |
BSA indicates body surface area; Endo, endocardium; Epi, epicardium; LAVA, local abnormal ventricular activities; MDCT, multidetector computed tomography; RVEDV, right ventricular endo‐diastolic volume.